Question 1

How many shares of SYRE does LOS ANGELES CAPITAL MANAGEMENT LLC own?

Accepted Answer

As of 2026-Q2, LOS ANGELES CAPITAL MANAGEMENT LLC holds 2,310 shares of SYRE (SPYRE THERAPEUTICS INC).

Question 2

What is LOS ANGELES CAPITAL MANAGEMENT LLC's SYRE position worth?

Accepted Answer

As of 2026-Q2, LOS ANGELES CAPITAL MANAGEMENT LLC's SYRE position is worth $205,082.

Question 3

Is LOS ANGELES CAPITAL MANAGEMENT LLC buying or selling SYRE?

Accepted Answer

In 2026-Q2, LOS ANGELES CAPITAL MANAGEMENT LLC decreased their SYRE position (-60.6% change in shares).

Question 4

When did LOS ANGELES CAPITAL MANAGEMENT LLC first buy SYRE?

Accepted Answer

Based on available 13F filings, LOS ANGELES CAPITAL MANAGEMENT LLC first reported a position in SYRE in 2025-Q3. They have held the position across 4 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	2,310	-60.6%	$205,082	0.0%	$88.78	0
2026-Q1	Decreased	5,858	-54.5%	$295,477	0.0%	$40.07	0
2025-Q4	Decreased	12,882	-29.1%	$312,519	0.0%	$31.88	0
2025-Q3	New	18,172	—	$304,563	0.0%	$16.36	32